Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 4 Planned sale Director sold 137,041 shares at an average $1.13 ($154,850)
  5. 4 Planned sale 10% owner sold 213,529 shares at an average $1.13 ($241,278)
  6. 4 Planned sale 10% owner sold 213,529 shares at an average $1.13 ($241,278)
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Planned sale Director sold 155,885 shares at an average $1.22 ($189,830)
  14. 4 Planned sale 10% owner sold 242,890 shares at an average $1.22 ($295,781)
  15. 4 Planned sale 10% owner sold 242,890 shares at an average $1.22 ($295,781)
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. SCHEDULE 13D/A Stake Beneficial Ownership Report
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 9 of 23 · 453 filings